Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Fambir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 11 USDMF, 5 JDMF, 5 EU WC, 15 KDMF, 8 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

141 FDF Dossiers, 27 FDA Orange Book, 64 Europe, 9 Canada, 26 Australia, 6 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

46 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 37 Disintegrants & Superdisintegrants, 32 Direct Compression, 31 Granulation, 28 Thickeners and Stabilizers, 27 Solubilizers, 22 Lubricants & Glidants, 21 Controlled & Modified Release, 17 Topical, 14 Film Formers & Plasticizers, 11 Parenteral, 11 Co-Processed Excipients, 10 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Taste Masking, 2 Coloring Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 39 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

11 Others

11 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	CHANGZHOU KONY PHARMACEUTICAL CO., LTD. CN 213 105 Changzhou	China	Kosha Bio Co., Ltd.	20180208-209-J-153(4)	Famciclovir	2019-01-24	Changzhou Kony Pharmaceutical Co.,Ltd.	China	Daixi Street, Luoyang Town, Wujin District, Changzhou, Jiangsu China
31/03/2026	Charioteer	China	JL Bio Co., Ltd.	20210303-209-J-743(3)	Famciclovir	2025-09-05	Zhejiang Charioteer Pharmaceutical Co., Ltd.@Zhejiang Charioteer Pharmaceutical Co., Ltd.	China	Tongyuanxi, Dazhan, Xianju, Zhejiang Province, 317321, PR China@Fengxi West Road No.5, Modern Industry Zone, Xianju, Zhejiang Province, 317300, PR China

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Fambir

Fambir

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers

11 USDMF

5 JDMF

5 EU WC

15 KDMF

8 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

141 FDF Dossiers

27 FDA Orange Book

64 Europe

9 Canada

26 Australia

6 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 SPI Pharma

5 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Kirsch Pharma

1 Panvo Organics

1 Cerata Pharmaceuticals LLP

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

5 Actylis

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

28 BASF

1 Clariant

10 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

1 Finar

12 Gangwal Chemicals

2 Gloria Interchem

4 Ideal Cures

2 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

5 Pharmatrans-Sanaq

4 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons